We’re absolutely thrilled to have these amazing budding scientists join our vibrant community! Let’s embark on this journey together!

Dr. Goriounova successfully defended her thesis, “ELD607 is a novel, specific Orai1 inhibitor,” on May 10. Her PhD Advisor was Dr. Robert Tarran.

The award provides a stipend for travel expenses to the ACS Symposium in San Francisco this fall where she will present her research.

Pharmacology graduate student Kaitlan Smith was recently awarded a diversity supplement from the National Institute on Aging (NIA) to study the effects of aging and necroptosis. She shares her resilient journey into scientific research while reflecting on her Lumbee roots.

Dr. DiBerto successfully defended his thesis, “Discovery Campaigns for Pharmacologically Unique Agonists at the Mu-Opioid and 5-Hydroxytryptamine 2A Receptors on Jan. 19.”

Kaeli Welsh, PhD student in Nicholas Brown’s lab, received the Pre-doctoral Fellowship for her project, “Visualizing Essential Molecular Mechanisms That Promote Mitotic Exit.”

Emily won the Impact Award for her project “Multi-omic Analysis of Pharmacological ClpP Activation in Triple-Negative Breast Cancer Cells.

The NIH fellowship will support Madigan’s research in Opioid Withdrawal Syndrome.

Dr. Chappell defended her thesis, “KSHV Viral Protein Kinase (vPK) Interacts with USP9X to Modulate the Viral Lifecycle,” Nov. 30! Dr. Blossom Damania is her mentor.

The Bryan Roth lab got some nice press for their recent Nature paper, revealing structural details of his chemogenetic technology called DREADD – designer receptors exclusively activated by designer drugs – that recognize drug-like but physiologically inert compounds. Postdoc Shicheng Zhang, PhD, led this research published in Nature.